Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Ocella
|
| gptkbp:category |
Category X
|
| gptkbp:class |
gptkb:drug
|
| gptkbp:clinical_trial |
studies on efficacy
studies on safety studies on side effects |
| gptkbp:contraindication |
liver disease
certain cancers history of blood clots smoking over age 35 |
| gptkbp:dosage_form |
combination pill
|
| gptkbp:effective_date |
2006-01-01
|
| gptkbp:form |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ocella
|
| gptkbp:ingredients |
Drospirenone
Ethinyl estradiol |
| gptkbp:interacts_with |
gptkb:St._John's_Wort
antibiotics anticonvulsants |
| gptkbp:is_effective_against |
over 99% with perfect use
91% with typical use |
| gptkbp:is_used_for |
preventing pregnancy
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:marketed_as |
gptkb:legislation
gptkb:Australia gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:packaging |
blister pack
|
| gptkbp:population |
not for use during pregnancy
take at the same time each day consult doctor for side effects missed dose instructions available |
| gptkbp:previous_name |
Drospirenone and Ethinyl estradiol
|
| gptkbp:products |
gptkb:Yasmin
Yaz Beyaz Safyral |
| gptkbp:regulatory_compliance |
approved by FDA
approved by EMA approved by Health Canada approved by TGA |
| gptkbp:requires |
prescription only
|
| gptkbp:scholarships |
online resources available
available through pharmacies consultation with healthcare provider recommended |
| gptkbp:side_effect |
headache
nausea breast tenderness mood changes |
| gptkbp:storage |
room temperature
|
| gptkbp:bfsParent |
gptkb:ethinylestradiol
|
| gptkbp:bfsLayer |
6
|